Table 3.
Disease group | Specific disease | Gut microbes | Main findings |
---|---|---|---|
Autoimmune diseases | Rheumatoid arthritis | Prevotella copri., | Increased in abundance [12, 13] |
Collinsella sp., | Increased in abundance [13] | ||
Faecalibacterium sp. | Decreased in abundance, links to SCFA production [25] | ||
Type-1 diabetes | Dialister invisus., Gemella sanguinis., Bifidobacterium longum | Increased in abundance (children), gut permeability [25] | |
F. prausnitzii | Decreased in abundance (children), butyrate (SCFA) production [28] | ||
Atopic eczema | Clostridium difficile | Increased in abundance [37] | |
Escherichia coli | Increased in abundance, eosinophilic inflammation [37] | ||
Staphylococcus aureus | Increased in abundance [37] | ||
Bifidobacteria spp. | Decreased in abundance [37] | ||
Bacteroidetes spp. | Decreased in abundance [38, 39] | ||
Coprococcus eutactus | Decreased (in children), linked to butyrate production [39] | ||
F. prausnitizii | Increased in abundance, SCFA production [41] | ||
Atopic asthma | Various—Clostridium, Pediococcus, Escherichia, Klebsiella, Morganella, and Proteus spp. | Increased in abundance, increased bioamine (histamine) production [55] | |
Enterococcus faecalis, Streptococcus spp., Bifidobacterium bifidum., Lactobacillus spp. | Increased in abundance, increased bioamine (histamine) levels, increased epoxide hydrolase production of oxylipins (12,13-diHOME) [55, 56] | ||
Gut inflammation disorders | Irritable bowel syndrome | Ruminococcus spp., Clostridium spp., Dorea spp. | Increased in abundance [62] |
Bifidobacterium spp. | Decreased significantly in abundance (all IBS subtypes) [62, 68] | ||
Faecalibacterium spp. | Decreased in abundance, anti-inflammatory, butyrate production [62, 64, 65] | ||
Enterobacteriaceae spp. | Increased, links to previous intestinal infection and pathogen byproducts [63] | ||
Lactobacillaceae spp., Bacteroides spp. | Increased in abundance [63] | ||
Inflammatory bowel disease | Ruminococcaceae spp., Lachnospiraceae spp. | Decreased in microbiome, butyrate production [78–81] | |
Faecalibacterium prausnitzii, Roseburia sp. | Decreased in microbiome, butyrate production [83] | ||
Cardiometabolic diseases | Cardiovascular disease (including hypertension) | Lactobacillus plantarum, Lactobacillus rhamnosus | Improved ventricular function and attenuated heart failure after myocardial infarction [90, 107]. Improved blood pressure [110] |
Akkermansia muciniphila | Protected against atherosclerosis in mice [111] | ||
Type-2 diabetes | Bifidobacterium, Bacteroides, Faecalibacterium Akkermansia and Roseburia spp. | Negative association [112, 113] | |
Ruminococcus, Fusobacterium, and Blautia | Positive association [112, 113] | ||
Lactobacillus spp. | Enriched in control microbiome, butyrate production [112, 114, 115], insulin sensitivity through GLP-1 [116–120] | ||
Clostridium spp. | Increased, opportunistic pathogen | ||
NAFLD | Collinsell spp. | Increased in abundance [128]. Increased intestinal permeability and lipopolysaccharide release through metabolism of bile-acids to oxo-bile [144, 145] | |
Escherichia spp., Dorea spp. | Increased in abundance [131, 135, 136] | ||
Coprococcus spp., Eubacterium spp., Faecalibacterium spp., Prevotella spp. |
Decreased in abundance [131, 135, 137] | ||
Chronic kidney disease | Bifidobacterium, Lactobacillaceae, Prevotellaceae | Decreased in abundance, SCFA producers associated with anti-inflammatory cytokines [148, 149] | |
Enterobacter | Increased in abundance [149] | ||
Klebsiella | Increased in abundance, pathogen associated with inflammatory disease states including Crohn’s [148, 149] | ||
Clostridium perfringes | Increased in abundance, pathogen associated with intestinal diseases [148] | ||
Mental health disorders | SCZ, ADHD | Lactobacillus spp, Bifidobacterium | Increased in abundance in specific disorders such as SCZ and ADHD [157, 158] |
General anxiety disorder (GAD) |
Bacteriodetes, Ruminococcus gnavus, and Fusobacterium Bacteroidaceae, Enterobacteriaceae, and Burkholderiaceae |
Decreased in abundance in general anxiety disorder (GAD) [170]. Increased in abundance in GAD [171, 172] | |
Post- traumatic stress disorder (PTSD) | Actinobacteria, Lentisphaerae, and Verrucomicrobia | Decreased in abundance in post-traumatic stress disorder (PTSD) [173] | |
Depression |
Eggerthella., Holdemania, Turicibacter, Paraprevotella Prevotella, Dialister |
Increased in abundance amongst individuals with depression [174, 175]. Decreased in abundance amongst individuals with depression [176] |
|
Dementia | Escherichia, Blautia, Bifidobacterium, Streptococcus, Lactobacillus, Dorea spp Actinobacteria, Bacteroides | Increased in abundance amongst individuals with dementia [177]. Decreased in abundance amongst individuals with dementia [177] |